Why will we succeed where others have failed?
If there is a company to achieve this goal, it is Pyrexar Medical. We have the equipment, advanced technology, and clinical expertise to attack this disease head-on.
Timeline
RF Phased Array
Originally developed for military applications, the annular phased array concept is discovered and developed used to focus and steer Non-Ionizing Radiation into the body
1980
BSD-500 Released
The BSD-500 Superficial Interstitial Hyperthermia system is designed to treat cancer tumors incorporating microwave phased array technology
1985
FDA Approved
The BSD-500 is FDA approved to treat tumors in the body
1986
CE mark
Products certified for sale in Europe on the CE mark
1992
BSD-2000 Released
The BSD-2000 is developed for deep phased-array electronic control of phase and power amplitude controls including numerical modeling for steering controls and planning.
1988
3D Electronic Steering
Development of SigmaEye 24 dipole phased array providing 3D electronic steering of phase and power amplitude
1996
Treatment Planning Software
Development of SigmaHyperPlan for phased array numerical pretreatment planning and guidance of steering parameter selection
1996
Non-Invasive Imaging
First commercial integration of the BSD-2000-3D/MR with a 0.2T MR non-invasive temperature imaging.
1998
Real Time Temperature Monitoring
First commercial integration of the BSD-2000-3D/MR with a 1.5T MRI and Sigma Vision Advanced software allowing real-time monitoring of temperature during treatment.
2003
FDA HDE Approved
BSD-2000 receives HDE FDA clearance for commercial sales and use in the U.S.
2011
Control Software Update
System update to provide simplified touchscreen control of the system
2016
New Head Applicator Designed
A new applicator was designed to place antenna array in the correct attitude around the brain
Feb 2018
Multi-Physics Simulation
Computer modeling used to determine the antenna configuration to provide optimal energy focus within the brain.
June 2018
ESHO and STM Presentation
Presented our brain phased array development and results to the European Society of Hyperthermic Oncology in Berlin and the Society of Thermal Medicine.
May 2018
MRI Phantom Testing of Brain Array
Prototype testing to validate computer simulations at The University Hospital Erlangen, Germany
November 2018
Design Updates
Optimization of antenna configuration and RF controls planned.
February 2019
Covid-19 Shutdown
The company temporarily shut down offices and research center
March-July 2020
US Patent Awarded
Apparatus and Method for Creating Small Focus Deep Hyperthermia in Tissues of the Brain
August 2020
Remote Workforce
Mandated work from home during Covid Lockdown temporarily delays progress
July 2020 - May 2021
Fully functional prototype ready for clinical trials
Q4 2021
ESHO Presentation
Physicist Dr. Dario Rodriguez presents work at the European Society of Hyperthermic Oncology
September 2023
NIH Grant Application
Proposal for a NIH grant Animal Study of the Hal.o Applicator
Q4 2023
Animal Study
Testing applicator on Mini Pig
Q1 2024
Phase 1 Study
Phase 1 clinical human study at the University of Maryland
Q4 2024
Phase II Study
Clinical Phase II efficacy study at the University of Maryland, US and Samsung Medical Hospital in Seoul, Korea
Q2 2026